FDA Seeks Expanded Authority To Regulate Postapproval Manufacturing Changes
BioSpace
Aiming to protect patients, the FDA sent lawmakers a wish list of legislative proposals intended to clarify and expand its oversight of updates to approved drug production processes.
pharminent
April 7, 2026 (Last updated: April 7, 2026)
BioSpace
Aiming to protect patients, the FDA sent lawmakers a wish list of legislative proposals intended to clarify and expand its oversight of updates to approved drug production processes.
